As Brexit Row Becomes Increasingly Anarchic, Is UK's Reputation with Pharma Suffering?, Pharmaphorum

Jeffry Mann and Paul Ranson provide their perspectives on how discussions around Brexit are affecting life sciences companies and the potential future implications.

Read the full Pharmaphorum article.